HomeRLMD • NASDAQ
add
Relmada Therapeutics Inc
Previous close
$3.28
Day range
$3.16 - $3.48
Year range
$1.88 - $7.22
Market cap
103.56M USD
Avg Volume
238.34K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 18.82M | -27.69% |
Net income | -17.77M | 29.78% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 70.44M | -40.57% |
Total assets | 71.03M | -41.80% |
Total liabilities | 9.54M | -10.89% |
Total equity | 61.49M | — |
Shares outstanding | 30.17M | — |
Price to book | 1.61 | — |
Return on assets | -60.54% | — |
Return on capital | -70.46% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -17.77M | 29.78% |
Cash from operations | -13.26M | 0.08% |
Cash from investing | 14.01M | 1,316.79% |
Cash from financing | 0.00 | — |
Net change in cash | 751.24K | 105.21% |
Free cash flow | -14.37M | 10.44% |
About
Headquarters
Website
Employees
20
